In the canonical pathway, cell cycle G1/S checkpoint regulation integrated three genes (TP53, CDKN2, and RB1); despite this, the loss of function mutations’ effects of TP53 were sufficient to predict activated the development of breast carcinoma. The gene discussed is RB1; the disease is breast carcinoma.